Chad Dickey, Ph.D.

Assoc Professor, College Of Medicine Molecular Medicine

College Of Medicine Molecular Medicine

Assistant Professor, Department of Molecular Medicine-University of South Florida, College of Medicine, Johnnie B. Byrd Sr. Alzheimer's Center and Research Institute

Contact Info 4001 E. Fletcher Ave. Rm# 338
USF Health Byrd Alzheimer's Insititute
Tampa, FL 33613

Academic Email:

Academic Phone: (813) 396-0639


  • PHD, Pharmacology/Neuroscience, University Of South Florida, 2004
  • B.S., Microbiology, University of South Florida, 1998

Interdisciplinary and Emerging Signature Programs

  • Neuroscience

Research Interests

  • My research interests lie with the molecular mechanisms involved in protein turnover and degradation, particularly in the brain. My recent focus has been on the role of molecular chaperones in a group of diseases termed tauopathies, the most common of which is Alzheimer’s disease. The microtubule associated protein tau is abnormally phosphorylated and accumulates in these diseases, and we have established that the degradation machinery involved in tau metabolism may be a major contributor to this aberrant accretion. We are in the process of identifying other molecular chaperones that may be involved in tau biology, apart from those that we have already established. We are currently administering AAV constructs to our transgenic tau mouse model in an effort to determine the in vivo consequence of knockdown and over-expression of individual chaperones on tau pathology. We are also working with Dr. Henry Paulson at the University of Michigan on how these same mechanisms might be relevant for polyQ expansion diseases.
  • We are taking a more structural approach to investigating the relationship of tau with chaperones. We have begun using NMR as well as other biophysical techniques to investigate the binding of tau to specific chaperone proteins. We are using dynamic light scattering to investigate tau aggregation kinetics in the presence of chaperones, and we are working toward a technique to actually measure binding affinities of chaperones for tau. In collaboration with Dr. Hunt Potter here at USF, we have also developed a method to study the effects of chaperones on microtubule polymerization using Xenopus oocyte extracts. These molecular tools allow us to better understand the mechanisms of the tau/chaperone interface and how this might impact pathogenesis.
  • We have developed and utilized a cell-based drug screening process called the In-Cell Western, and in collaboration with Dr. Bill Baker, we have begun screening a novel library of extracts acquired from the Antarctic Ocean. Using extraction and mass spec technologies, we are able to identify specific compounds from these extracts once it has been determined that they reduce tau levels. We are working on several leads from these screens.
  • More recently, we have been exploring the role of chaperones in cancer biology. We have been developing compounds that can selectively target cancer cells through inhibition of the chaperone Hsp70. In addition we have found that these compounds may be able to overcome drug resistance that has developed in refractory breast cancer.
  • The program that I have established should be of great interest to the neurodegenerative disease and aging communities at large. These mechanisms may be relevant for other diseases of aging, including Parkinson’s, Huntington’s, amyolateral sclerosis and cancer. The turnover of abnormally modified or mutant proteins is critical in most diseases, and my hope is that the studies my team is leading will help to pave the way for future therapeutic development.


  • American Society for Cell Biology (Member, 2007 - Present)
  • Society for Neuroscience (Member, 2002 - Present)
  • University of South Florida Alumni Association (Member, 1998 - Present)
  • Institute for Biomolecular Sciences (USF) (Member, 2000 - 2002)

Recent Publications

  • Karagöz, GE.Duarte, AM.Akoury, E.Ippel, H.Biernat, J.Morán Luengo, T.Radli, M.Didenko, T.Nordhues, BA.Veprintsev, DB.Dickey, CA.Mandelkow, E.Zweckstetter, M.Boelens, R.Madl, T.Rüdiger, SG. Hsp90-Tau complex reveals molecular basis for specificity in chaperone action. Cell. 156(5) : 963-74, 2014.
  • Orwig, SD.Chi, PV.Du, Y.Hill, SE.Cavitt, MA.Suntharalingam, A.Turnage, KC.Dickey, CA.France, S.Fu, H.Lieberman, RL. Ligands for glaucoma-associated myocilin discovered by a generic binding assay. ACS chemical biology. 9(2) : 517-25, 2014.
  • Blair, LJ.Zhang, B.Dickey, CA. Potential synergy between tau aggregation inhibitors and tau chaperone modulators. Alzheimer's research & therapy. 5(5) : 41, 2013.
  • Smith, MC.Scaglione, KM.Assimon, VA.Patury, S.Thompson, AD.Dickey, CA.Southworth, DR.Paulson, HL.Gestwicki, JE.Zuiderweg, ER. The E3 ubiquitin ligase CHIP and the molecular chaperone Hsc70 form a dynamic, tethered complex. Biochemistry. 52(32) : 5354-64, 2013.
  • Jinwal, UK.Koren, J.Dickey, CA. Reconstructing the Hsp90/Tau Machine. Current enzyme inhibition. 9(1) : 41-45, 2013.
  • Abisambra, JF.Jinwal, UK.Blair, LJ.O'Leary, JC.Li, Q.Brady, S.Wang, L.Guidi, CE.Zhang, B.Nordhues, BA.Cockman, M.Suntharalingham, A.Li, P.Jin, Y.Atkins, CA.Dickey, CA. Tau accumulation activates the unfolded protein response by impairing endoplasmic reticulum-associated degradation. The Journal of neuroscience : the official journal of the Society for Neuroscience. 33(22) : 9498-507, 2013.
  • Abisambra, J.Jinwal, UK.Miyata, Y.Rogers, J.Blair, L.Li, X.Seguin, SP.Wang, L.Jin, Y.Bacon, J.Brady, S.Cockman, M.Guidi, C.Zhang, J.Koren, J.Young, ZT.Atkins, CA.Zhang, B.Lawson, LY.Weeber, EJ.Brodsky, JL.Gestwicki, JE.Dickey, CA. Allosteric heat shock protein 70 inhibitors rapidly rescue synaptic plasticity deficits by reducing aberrant tau. Biological psychiatry. 74(5) : 367-74, 2013.
  • Lee, DC.Ruiz, CR.Lebson, L.Selenica, ML.Rizer, J.Hunt, JB.Rojiani, R.Reid, P.Kammath, S.Nash, K.Dickey, CA.Gordon, M.Morgan, D. Aging enhances classical activation but mitigates alternative activation in the central nervous system. Neurobiology of aging. 34(6) : 1610-20, 2013.
  • Miyata, Y.Li, X.Lee, HF.Jinwal, UK.Srinivasan, SR.Seguin, SP.Young, ZT.Brodsky, JL.Dickey, CA.Sun, D.Gestwicki, JE. Synthesis and initial evaluation of YM-08, a blood-brain barrier permeable derivative of the heat shock protein 70 (Hsp70) inhibitor MKT-077, which reduces tau levels. ACS chemical neuroscience. 4(6) : 930-9, 2013.
  • Braswell, K.Dickey, CA.Jinwal, UK. A commentary on: Modulating molecular chaperones improves sensory fiber recovery and mitochondrial function in diabetic peripheral neuropathy. Experimental neurology. 241: 122-4, 2013.
  • Chiosis, G.Dickey, CA.Johnson, JL. A global view of Hsp90 functions. Nature structural & molecular biology. 20(1) : 1-4, 2013.
  • Jinwal, UK.Akoury, E.Abisambra, JF.O'Leary, JC.Thompson, AD.Blair, LJ.Jin, Y.Bacon, J.Nordhues, BA.Cockman, M.Zhang, J.Li, P.Zhang, B.Borysov, S.Uversky, VN.Biernat, J.Mandelkow, E.Gestwicki, JE.Zweckstetter, M.Dickey, CA. Imbalance of Hsp70 family variants fosters tau accumulation. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 27(4) : 1450-9, 2013.
  • Selenica, ML.Brownlow, M.Jimenez, JP.Lee, DC.Pena, G.Dickey, CA.Gordon, MN.Morgan, D. Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy. Neuro-degenerative diseases. 11(4) : 165-81, 2013.
  • Blair, LJ.Nordhues, BA.Hill, SE.Scaglione, KM.O'Leary, JC.Fontaine, SN.Breydo, L.Zhang, B.Li, P.Wang, L.Cotman, C.Paulson, HL.Muschol, M.Uversky, VN.Klengel, T.Binder, EB.Kayed, R.Golde, TE.Berchtold, N.Dickey, CA. Accelerated neurodegeneration through chaperone-mediated oligomerization of tau. The Journal of clinical investigation. 123(10) : 4158-69, 2013.
  • O'Leary, JC.Zhang, B.Koren, J.Blair, L.Dickey, CA. The role of FKBP5 in mood disorders: action of FKBP5 on steroid hormone receptors leads to questions about its evolutionary importance. CNS & neurological disorders drug targets. 12(8) : 1157-62, 2013.
  • Jinwal, UK.Abisambra, JF.Zhang, J.Dharia, S.O'Leary, JC.Patel, T.Braswell, K.Jani, T.Gestwicki, JE.Dickey, CA. Cdc37/Hsp90 protein complex disruption triggers an autophagic clearance cascade for TDP-43 protein. The Journal of biological chemistry. 287(29) : 24814-20, 2012.
  • Thompson, AD.Scaglione, KM.Prensner, J.Gillies, AT.Chinnaiyan, A.Paulson, HL.Jinwal, UK.Dickey, CA.Gestwicki, JE. Analysis of the tau-associated proteome reveals that exchange of Hsp70 for Hsp90 is involved in tau degradation. ACS chemical biology. 7(10) : 1677-86, 2012.
  • Calcul, L.Zhang, B.Jinwal, UK.Dickey, CA.Baker, BJ. Natural products as a rich source of tau-targeting drugs for Alzheimer's disease. Future medicinal chemistry. 4(13) : 1751-61, 2012.
  • Suntharalingam, A.Abisambra, JF.O'Leary, JC.Koren, J.Zhang, B.Joe, MK.Blair, LJ.Hill, SE.Jinwal, UK.Cockman, M.Duerfeldt, AS.Tomarev, S.Blagg, BS.Lieberman, RL.Dickey, CA. Glucose-regulated protein 94 triage of mutant myocilin through endoplasmic reticulum-associated degradation subverts a more efficient autophagic clearance mechanism. The Journal of biological chemistry. 287(48) : 40661-9, 2012.
  • Miyata, Y.Rauch, JN.Jinwal, UK.Thompson, AD.Srinivasan, S.Dickey, CA.Gestwicki, JE. Cysteine reactivity distinguishes redox sensing by the heat-inducible and constitutive forms of heat shock protein 70. Chemistry & biology. 19(11) : 1391-9, 2012.
  • Abisambra, JF.Jinwal, UK.Suntharalingam, A.Arulselvam, K.Brady, S.Cockman, M.Jin, Y.Zhang, B.Dickey, CA. DnaJA1 antagonizes constitutive Hsp70-mediated stabilization of tau. Journal of molecular biology. 421(4-5) : 653-61, 2012.
  • Congdon, EE.Wu, JW.Myeku, N.Figueroa, YH.Herman, M.Marinec, PS.Gestwicki, JE.Dickey, CA.Yu, WH.Duff, KE. Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo. Autophagy. 8(4) : 609-22, 2012.
  • Koren, J.Miyata, Y.Kiray, J.O'Leary, JC.Nguyen, L.Guo, J.Blair, LJ.Li, X.Li, X.Jinwal, UK.Cheng, JQ.Gestwicki, JE.Dickey, CA. Rhodacyanine derivative selectively targets cancer cells and overcomes tamoxifen resistance. PloS one. 7(4) : e35566, 2012.
  • Daily, JL.Nash, K.Jinwal, U.Golde, T.Rogers, J.Peters, MM.Burdine, RD.Dickey, C.Banko, JL.Weeber, EJ. Adeno-associated virus-mediated rescue of the cognitive defects in a mouse model for Angelman syndrome. PloS one. 6(12) : e27221, 2011.
  • Jinwal, UK.Dickey, CA. Cell-based assays for regulators of tau biology. Methods in molecular biology (Clifton, N.J.). 670: 93-108, 2011.
  • Evans, CG.Jinwal, UK.Makley, LN.Dickey, CA.Gestwicki, JE. Identification of dihydropyridines that reduce cellular tau levels. Chemical communications (Cambridge, England). 47(1) : 529-31, 2011.
  • Jones, JR.Lebar, MD.Jinwal, UK.Abisambra, JF.Koren, J.Blair, L.O'Leary, JC.Davey, Z.Trotter, J.Johnson, AG.Weeber, E.Eckman, CB.Baker, BJ.Dickey, CA. The diarylheptanoid (+)-aR,11S-myricanol and two flavones from bayberry (Myrica cerifera) destabilize the microtubule-associated protein tau. Journal of natural products. 74(1) : 38-44, 2011.
  • Jinwal, UK.Trotter, JH.Abisambra, JF.Koren, J.Lawson, LY.Vestal, GD.O'Leary, JC.Johnson, AG.Jin, Y.Jones, JR.Li, Q.Weeber, EJ.Dickey, CA. The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics. The Journal of biological chemistry. 286(19) : 16976-83, 2011.
  • Koren, J.Jinwal, UK.Davey, Z.Kiray, J.Arulselvam, K.Dickey, CA. Bending tau into shape: the emerging role of peptidyl-prolyl isomerases in tauopathies. Molecular neurobiology. 44(1) : 65-70, 2011.
  • O'Leary, JC.Koren, J.Dickey, CA. Neuronal life span versus health span: principles of natural selection at work in the degenerating brain. Journal of molecular neuroscience : MN. 45(3) : 467-72, 2011.
  • Rousaki, A.Miyata, Y.Jinwal, UK.Dickey, CA.Gestwicki, JE.Zuiderweg, ER. Allosteric drugs: the interaction of antitumor compound MKT-077 with human Hsp70 chaperones. Journal of molecular biology. 411(3) : 614-32, 2011.
  • Miyata, Y.Koren, J.Kiray, J.Dickey, CA.Gestwicki, JE. Molecular chaperones and regulation of tau quality control: strategies for drug discovery in tauopathies. Future medicinal chemistry. 3(12) : 1523-37, 2011.
  • Storer, CL.Dickey, CA.Galigniana, MD.Rein, T.Cox, MB. FKBP51 and FKBP52 in signaling and disease. Trends in endocrinology and metabolism: TEM. 22(12) : 481-90, 2011.
  • Abisambra, JF.Jinwal, UK.Jones, JR.Blair, LJ.Koren, J.Dickey, CA. Exploiting the diversity of the heat-shock protein family for primary and secondary tauopathy therapeutics. Current neuropharmacology. 9(4) : 623-31, 2011.
  • Trotter, JH.Klein, M.Jinwal, UK.Abisambra, JF.Dickey, CA.Tharkur, J.Masiulis, I.Ding, J.Locke, KG.Rickman, CB.Birch, DG.Weeber, EJ.Herz, J. ApoER2 function in the establishment and maintenance of retinal synaptic connectivity. The Journal of neuroscience : the official journal of the Society for Neuroscience. 31(40) : 14413-23, 2011.
  • Voss, K.Koren, J.Dickey, CA. The earliest tau dysfunction in Alzheimer's disease? Tau phosphorylated at s422 as a toxic seed. The American journal of pathology. 179(5) : 2148-51, 2011.
  • O'Leary, JC.Dharia, S.Blair, LJ.Brady, S.Johnson, AG.Peters, M.Cheung-Flynn, J.Cox, Erausquin, G.Weeber, EJ.Jinwal, UK.Dickey, CA. A new anti-depressive strategy for the elderly: ablation of FKBP5/FKBP51. PloS one. 6(9) : e24840, 2011.
  • Lebson, L.Nash, K.Kamath, S.Herber, D.Carty, N.Lee, DC.Li, Q.Szekeres, K.Jinwal, U.Koren, J.Dickey, CA.Gottschall, PE.Morgan, D.Gordon, MN. Trafficking CD11b-positive blood cells deliver therapeutic genes to the brain of amyloid-depositing transgenic mice. The Journal of neuroscience : the official journal of the Society for Neuroscience. 30(29) : 9651-8, 2010.
  • Lee, DC.Rizer, J.Selenica, ML.Reid, P.Kraft, C.Johnson, A.Blair, L.Gordon, MN.Dickey, CA.Morgan, D. LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice. Journal of neuroinflammation. 7: 56, 2010.
  • Carty, N.Lee, D.Dickey, C.Ceballos-Diaz, C.Jansen-West, K.Golde, TE.Gordon, MN.Morgan, D.Nash, K. Convection-enhanced delivery and systemic mannitol increase gene product distribution of AAV vectors 5, 8, and 9 and increase gene product in the adult mouse brain. Journal of neuroscience methods. 194(1) : 144-53, 2010.
  • Jinwal, UK.Koren, J.Borysov, SI.Schmid, AB.Abisambra, JF.Blair, LJ.Johnson, AG.Jones, JR.Shults, CL.O'Leary, JC.Jin, Y.Buchner, J.Cox, MB.Dickey, CA. The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules. The Journal of neuroscience : the official journal of the Society for Neuroscience. 30(2) : 591-9, 2010.
  • Koren, J.Jinwal, UK.Jin, Y.O'Leary, J.Jones, JR.Johnson, AG.Blair, LJ.Abisambra, JF.Chang, L.Miyata, Y.Cheng, AM.Guo, J.Cheng, JQ.Gestwicki, JE.Dickey, CA. Facilitating Akt clearance via manipulation of Hsp70 activity and levels. The Journal of biological chemistry. 285(4) : 2498-505, 2010.
  • Azorsa, DO.Robeson, RH.Frost, D.Meec hoovet, B.Brautigam, GR.Dickey, C.Beaudry, C.Basu, GD.Holz, DR.Hernandez, JA.Bisanz, KM.Gwinn, L.Grover, A.Rogers, J.Reiman, EM.Hutton, M.Stephan, DA.Mousses, S.Dunckley, T. High-content siRNA screening of the kinome identifies kinases involved in Alzheimer's disease-related tau hyperphosphorylation. BMC genomics. 11: 25, 2010.
  • Abisambra, JF.Blair, LJ.Hill, SE.Jones, JR.Kraft, C.Rogers, J.Koren, J.Jinwal, UK.Lawson, L.Johnson, AG.Wilcock, D.O'Leary, JC.Jansen-West, K.Muschol, M.Golde, TE.Weeber, EJ.Banko, J.Dickey, CA. Phosphorylation dynamics regulate Hsp27-mediated rescue of neuronal plasticity deficits in tau transgenic mice. The Journal of neuroscience : the official journal of the Society for Neuroscience. 30(46) : 15374-82, 2010.
  • Jinwal, UK.O'Leary, JC.Borysov, SI.Jones, JR.Li, Q.Koren, J.Abisambra, JF.Vestal, GD.Lawson, LY.Johnson, AG.Blair, LJ.Jin, Y.Miyata, Y.Gestwicki, JE.Dickey, CA. Hsc70 rapidly engages tau after microtubule destabilization. The Journal of biological chemistry. 285(22) : 16798-805, 2010.
  • Jinwal, UK.Koren, J.O'Leary, JC.Jones, JR.Abisambra, JF.Dickey, CA. Hsp70 ATPase Modulators as Therapeutics for Alzheimer's and other Neurodegenerative Diseases. Molecular and cellular pharmacology. 2(2) : 43-46, 2010.
  • O'Leary, JC.Li, Q.Marinec, P.Blair, LJ.Congdon, EE.Johnson, AG.Jinwal, UK.Koren, J.Jones, JR.Kraft, C.Peters, M.Abisambra, JF.Duff, KE.Weeber, EJ.Gestwicki, JE.Dickey, CA. Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden. Molecular neurodegeneration. 5: 45, 2010.
  • Jinwal, UK.Miyata, Y.Koren, J.Jones, JR.Trotter, JH.Chang, L.O'Leary, J.Morgan, D.Lee, DC.Shults, CL.Rousaki, A.Weeber, EJ.Zuiderweg, ER.Gestwicki, JE.Dickey, CA. Chemical manipulation of hsp70 ATPase activity regulates tau stability. The Journal of neuroscience : the official journal of the Society for Neuroscience. 29(39) : 12079-88, 2009.
  • Koren, J.Jinwal, UK.Lee, DC.Jones, JR.Shults, CL.Johnson, AG.Anderson, LJ.Dickey, CA. Chaperone signalling complexes in Alzheimer's disease. Journal of cellular and molecular medicine. 13(4) : 619-30, 2009.
  • Dickey, C.Kraft, C.Jinwal, U.Koren, J.Johnson, A.Anderson, L.Lebson, L.Lee, D.Dickson, Silva, R.Binder, LI.Morgan, D.Lewis, J. Aging analysis reveals slowed tau turnover and enhanced stress response in a mouse model of tauopathy. The American journal of pathology. 174(1) : 228-38, 2009.
  • Dickey, CA.Koren, J.Zhang, YJ.Xu, YF.Jinwal, UK.Birnbaum, MJ.Monks, B.Sun, M.Cheng, JQ.Patterson, C.Bailey, RM.Dunmore, J.Soresh, S.Leon, C.Morgan, D.Petrucelli, L. Akt and CHIP coregulate tau degradation through coordinated interactions. Proceedings of the National Academy of Sciences of the United States of America. 105(9) : 3622-7, 2008.
  • Dickey, CA.Patterson, C.Dickson, D.Petrucelli, L. Brain CHIP: removing the culprits in neurodegenerative disease. Trends in molecular medicine. 13(1) : 32-8, 2007.
  • Dickey, CA.Kamal, A.Lundgren, K.Klosak, N.Bailey, RM.Dunmore, J.Ash, P.Shoraka, S.Zlatkovic, J.Eckman, CB.Patterson, C.Dickson, DW.Nahman, NS.Hutton, M.Burrows, F.Petrucelli, L. The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. The Journal of clinical investigation. 117(3) : 648-58, 2007.
  • Zhang, YJ.Xu, YF.Dickey, CA.Buratti, E.Baralle, F.Bailey, R.Pickering-Brown, S.Dickson, D.Petrucelli, L. Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43. The Journal of neuroscience : the official journal of the Society for Neuroscience. 27(39) : 10530-4, 2007.
  • Dickey, CA.Yue, M.Lin, WL.Dickson, DW.Dunmore, JH.Lee, WC.Zehr, C.West, G.Cao, S.Clark, AM.Caldwell, GA.Caldwell, KA.Eckman, C.Patterson, C.Hutton, M.Petrucelli, L. Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho- and caspase-3-cleaved tau species. The Journal of neuroscience : the official journal of the Society for Neuroscience. 26(26) : 6985-96, 2006.
  • Baker, M.Mackenzie, IR.Pickering-Brown, SM.Gass, J.Rademakers, R.Lindholm, C.Snowden, J.Adamson, J.Sadovnick, AD.Rollinson, S.Cannon, A.Dwosh, E.Neary, D.Melquist, S.Richardson, A.Dickson, D.Berger, Z.Eriksen, J.Robinson, T.Zehr, C.Dickey, CA.Crook, R.McGowan, E.Mann, D.Boeve, B.Feldman, H.Hutton, M. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 442(7105) : 916-9, 2006.
  • Dickey, CA.Ash, P.Klosak, N.Lee, WC.Petrucelli, L.Hutton, M.Eckman, CB. Pharmacologic reductions of total tau levels; implications for the role of microtubule dynamics in regulating tau expression. Molecular neurodegeneration. 1: 6, 2006.
  • Dickey, CA.Petrucelli, L. Current strategies for the treatment of Alzheimer's disease and other tauopathies. Expert opinion on therapeutic targets. 10(5) : 665-76, 2006.
  • Lee, WC.Tsoi, YK.Dickey, CA.Delucia, MW.Dickson, DW.Eckman, CB. Suppression of galactosylceramidase (GALC) expression in the twitcher mouse model of globoid cell leukodystrophy (GLD) is caused by nonsense-mediated mRNA decay (NMD). Neurobiology of disease. 23(2) : 273-80, 2006.
  • Dickey, CA.Dunmore, J.Lu, B.Wang, JW.Lee, WC.Kamal, A.Burrows, F.Eckman, C.Hutton, M.Petrucelli, L. HSP induction mediates selective clearance of tau phosphorylated at proline-directed Ser/Thr sites but not KXGS (MARK) sites. The FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 20(6) : 753-5, 2006.
  • Lee, WC.Courtenay, A.Troendle, FJ.Stallings-Mann, ML.Dickey, CA.DeLucia, MW.Dickson, DW.Eckman, CB. Enzyme replacement therapy results in substantial improvements in early clinical phenotype in a mouse model of globoid cell leukodystrophy. The FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 19(11) : 1549-51, 2005.
  • Dickey, CA.Eriksen, J.Kamal, A.Burrows, F.Kasibhatla, S.Eckman, CB.Hutton, M.Petrucelli, L. Development of a high throughput drug screening assay for the detection of changes in tau levels -- proof of concept with HSP90 inhibitors. Current Alzheimer research. 2(2) : 231-8, 2005.
  • Dickey, CA.Gordon, MN.Wilcock, DM.Herber, DL.Freeman, MJ.Morgan, D. Dysregulation of Na+/K+ ATPase by amyloid in APP+PS1 transgenic mice. BMC neuroscience. 6: 7, 2005.
  • Dickey, CA.De Mesquita, DD.Morgan, D.Pennypacker, KR. Induction of memory-associated immediate early genes by nerve growth factor in rat primary cortical neurons and differentiated mouse Neuro2A cells. Neuroscience letters. 366(1) : 10-4, 2004.
  • Garcia, MF.Gordon, MN.Hutton, M.Lewis, J.McGowan, E.Dickey, CA.Morgan, D.Arendash, GW. The retinal degeneration (rd) gene seriously impairs spatial cognitive performance in normal and Alzheimer's transgenic mice. Neuroreport. 15(1) : 73-7, 2004.
  • Dickey, CA.Gordon, MN.Mason, JE.Wilson, NJ.Diamond, DM.Guzowski, JF.Morgan, D. Amyloid suppresses induction of genes critical for memory consolidation in APP + PS1 transgenic mice. Journal of neurochemistry. 88(2) : 434-42, 2004.
  • Dickey, CA.Loring, JF.Montgomery, J.Gordon, MN.Eastman, PS.Morgan, D. Selectively reduced expression of synaptic plasticity-related genes in amyloid precursor protein + presenilin-1 transgenic mice. The Journal of neuroscience : the official journal of the Society for Neuroscience. 23(12) : 5219-26, 2003.
  • Dickey, CA.Morgan, DG.Kudchodkar, S.Weiner, DB.Bai, Y.Cao, C.Gordon, MN.Ugen, KE. Duration and specificity of humoral immune responses in mice vaccinated with the Alzheimer's disease-associated beta-amyloid 1-42 peptide. DNA and cell biology. 20(11) : 723-9, 2001.

Positions Held

  • Assistant Professor (Department of Molecular Pharmacology and Physiology, University of South Florida 2006 - 2008)
  • Senior Research Fellow (Department of Neuroscience, Mayo Clinic Jacksonville 2005 - 2006)
  • Research Fellow (Department of Neuroscience, Mayo Clinic 2004 - 2005)


  • Rosalinde and Arthur Gilbert Foundation/AFAR New Investigator Awards in Alzheimer's Disease 2007)
  • Smith Award Recipient (Mayo Clinic Jacksonville - 2006)
  • ADRC Pilot Study Award Recipient 2006)
  • University of South Florida Department of Pharmacology Stipend Award (University of South Florida - 2004)
  • Institute for Biomolecular Sciences Competitive Stipend Award (University of South Florida - 2002)